Мы используем файлы cookie.
Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
Peforelin
Подписчиков: 0, рейтинг: 0
Clinical data | |
---|---|
Trade names | Maprelin |
Other names | Lamprey GnRH-III; H-Pyr-His-Trp-Ser-His-Asp-Trp-Lys-Pro-Gly-NH2; XHWSHDWKPG |
Routes of administration |
Injection |
Drug class | GnRH agonist |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.223.356 |
Chemical and physical data | |
Formula | C59H74N18O14 |
Molar mass | 1259.353 g·mol−1 |
3D model (JSmol) | |
| |
|
Peforelin (INN), or peforelin acetate, sold under the brand name Maprelin, is a gonadotropin-releasing hormone agonist (GnRH agonist) medication which is used in veterinary medicine in Europe and Canada. It is a GnRH analogue and a synthetic peptide, specifically a decapeptide. The drug was introduced for veterinary use by 2001.
See also
GnRH |
|
||||
---|---|---|---|---|---|
Gonadotropin |
|